UTAH MEDICAL PRODUCTS, INC. Notes Payable, Noncurrent
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Notes Payable, Noncurrent of $0 as of 2015-12-31, per its 10-K filed 2016-03-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermNotesPayable · last filed 2016-03-10
- 2015-12-31: Notes Payable, Noncurrent $0.00.
- 2015-09-30: Notes Payable, Noncurrent $0.00.
- 2015-06-30: Notes Payable, Noncurrent $0.00.
- 2015-03-31: Notes Payable, Noncurrent $0.00.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-10 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-07 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-06 |
| 2014-12-31 | $973.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $2.00M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $3.10M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $4.07M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $5.07M 10-K · filed 2015-03-12 |
| 2013-09-30 | $5.98M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $6.71M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $7.66M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $9.00M 10-K · filed 2014-03-12 |
| 2012-09-30 | $9.41M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $11.15M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $14.04M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $16.24M 10-K · filed 2013-03-07 |
| 2011-09-30 | $18.54M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $20.59M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $909.00K 10-K/A · filed 2012-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |